Bente Lund

Aalborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.

Journal: The New England journal of medicine

Published: December 07, 2021

The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness.

The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 02, 2021

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.

Journal: The Lancet. Oncology

Published: October 08, 2020

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Journal: The New England journal of medicine

Published: September 29, 2019

Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies.

Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies.

Journal: Gynecologic oncology

Published: July 14, 2019

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 08, 2019

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.

Journal: The Lancet. Oncology

Published: May 05, 2019

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.

Journal: The Lancet. Oncology

Published: January 30, 2018

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer.

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer.

Journal: Oncology letters

Published: February 16, 2016

Successful treatment of primary small cell neuroendocrine carcinoma of the cervix

Successful treatment of primary small cell neuroendocrine carcinoma of the cervix

Journal: Ugeskrift for laeger

Published: November 29, 2014

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer.

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer.

Journal: BMC cancer

Published: May 13, 2014

Primary malignant melanoma of the vagina

Primary malignant melanoma of the vagina

Journal: Ugeskrift for laeger

Published: January 22, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026